Company Performance Metrics
Polireddy Dondeti: Founder and President & CEO
Tatiana Akimova: Executive Vice President
Saptalis Pharmaceuticals is a pharmaceutical company that develops complex generics and difficult to formulate dosage forms. They aim to achieve their goals through their strong science-driven, cost-effective, and time-efficient product development process leading to faster entry into the market.
The company operates at a 10,000 sq. ft. R&D
facility with a highly qualified and experienced team of pharmaceutical formulation scientists, analytical chemists, and compliance specialists in regulatory affairs and pharmaceutical product manufacturing. Their facility is fully equipped with state of the art equipment used in pharmaceutical product development and analytical method development and validation process.
Saptalis was founded in 2015 with a goal to build a successful pharmaceutical company focused on the development, manufacturing, and commercialization of specialty generic prescription (Rx) and Over-The-Counter (OTC) products.
